Evaluation of Safety and Efficacy of Keratin Hair Therapy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04489576 |
Recruitment Status : Unknown
Verified January 2021 by Amr Abdelhamed, Sohag University.
Recruitment status was: Recruiting
First Posted : July 28, 2020
Last Update Posted : January 11, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hair Damage | Procedure: Keratin hair treatment (Keratin Cure ®) versus (QOD Max ®) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 30 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Keratin hair application |
Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
Masking Description: | The participants, investigator and the outcome assessor will be blinded as regards the outcome measures evaluation |
Primary Purpose: | Treatment |
Official Title: | Efficacy and Safety of Keratin Hair Therapy on the Health of Hair and Scalp |
Actual Study Start Date : | November 15, 2020 |
Estimated Primary Completion Date : | April 2021 |
Estimated Study Completion Date : | June 2021 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Group (1): Treatment with keratin cure hair
Group (1): Patients will be treated with Keratin cure ® hair treatment. It will be applied once with use of a flat iron.
|
Procedure: Keratin hair treatment (Keratin Cure ®) versus (QOD Max ®)
Hair will be treated with 2 different types of keratin in groups 1 & 2. All steps of keratin application will be done in group 3 without keratin application as a control group.
Other Name: Hair straightening treatment |
Active Comparator: Group (2): Treatment with Qod max keratin hair
Group (2): Patients will be treated with QOD Max ® keratin hair treatment. It will be applied once with use of a flat iron.
|
Procedure: Keratin hair treatment (Keratin Cure ®) versus (QOD Max ®)
Hair will be treated with 2 different types of keratin in groups 1 & 2. All steps of keratin application will be done in group 3 without keratin application as a control group.
Other Name: Hair straightening treatment |
Placebo Comparator: Group (3): Treatment without keratin hair treatment
Group (3): Patients will be treated without keratin hair treatment, but the same steps of keratin application will be followed.
|
Procedure: Keratin hair treatment (Keratin Cure ®) versus (QOD Max ®)
Hair will be treated with 2 different types of keratin in groups 1 & 2. All steps of keratin application will be done in group 3 without keratin application as a control group.
Other Name: Hair straightening treatment |
- Change of hair shedding using the Visual analogue scale (VAS) [ Time Frame: Baseline, 2 months, 4 months, 6 months ]It will be used to evaluate hair shedding. Hair shedding is scored on a scale of 1-6. Women are asked to look at the scale and point to the photograph that best correlates with the amount of hair shed on an average day. Grades 1-3 are considered normal. Grade 4 is borderline, while Grades 5 and 6 indicate excessive shedding.
- Change of hair morphology using trichoscope [ Time Frame: Baseline, 2 months, 4 months, 6 months ]It will be used to evaluate hair structure and scalp. Hair density/cm 2 and thickness (mm) will be measured in the frontal, temporal and vertex areas in all participants.
- Change of hair morphology using Transmission Electron Microscopic examination [ Time Frame: Baseline, 2 months, 4 months, 6 months ]Randomly selected samples of each group will be fixed in 3% glutaraldehyde for over a period of 4 hours at 4°C and processed to be examined by transmission electron microscope
- Safety evaluation [ Time Frame: at 6 months ]to detect any side effects that will be reported either by the patient or by the physician.
- Change of patient satisfaction questionnaire about keratin treatment [ Time Frame: Baseline, 2 months, 4 months, 6 months ]A 5 items Questionnaire will be completed by the patients to evaluate their satisfaction about the treatment. The questionnaire consists of Q1 (1-5), Q2,3 (1-7), Q4 (1-4) and Q5 has 3 sub-items Q5a, Q5b, Q5c (1-5 for each). Total score ranges from 7-38. Higher scores are associated with higher dissatisfaction.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 55 Years (Adult) |
Sexes Eligible for Study: | Female |
Gender Based Eligibility: | Yes |
Gender Eligibility Description: | Female participants will be included as females are more interested in keratin hair straightening. |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- The study will include female patients aged between 18 and 55 years, with hair curl types from III to V according to L'Oréal Curl Classification. The Patients will be randomized by simple randomization into 3 groups, 10 patients for each.
Exclusion Criteria:
- Pregnant and lactating women.
- Patients having hair loss or under treatment of hair loss in last 3 months.
- Patients with previous history of keratin treatment.
- Patients with scalp affection including infection, injury or surgery
- Patients with chronic medical diseases.
- Patients with anemia (hemoglobin level <10mg/dl) or under its treatment.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04489576
Contact: Amr Abdelhamed, MD | +201005825574 ext 0020 | dramr80@yahoo.com |
Egypt | |
Sohag University | Recruiting |
Sohag, Egypt, 82524 | |
Contact: Amr Abdelhamed, MD 01005825574 dramr80@yahoo.com |
Principal Investigator: | Amr Abdelhamed, MD | Faculty of Medicine, Sohag University, Egypt |
Responsible Party: | Amr Abdelhamed, Associate professor, Department of Dermatology, Sohag University |
ClinicalTrials.gov Identifier: | NCT04489576 |
Other Study ID Numbers: |
Sohagu310 |
First Posted: | July 28, 2020 Key Record Dates |
Last Update Posted: | January 11, 2021 |
Last Verified: | January 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | Individual participant data sharing plan will include the study protocol, statistical analysis plan, and the clinical study report. |
Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Clinical Study Report (CSR) |
Time Frame: | Data will be available within 6 months after finishing the study. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Hair keratin Hair straightening |